5fbk - Revision history

OCA at 06:45, 19 July 2023

OCA — Wed, 19 Jul 2023 06:45:24 GMT

←Older revision		Revision as of 06:45, 19 July 2023
Line 3:		Line 3:
	<StructureSection load='5fbk' size='340' side='right'caption='[[5fbk]], [[Resolution\|resolution]] 2.10Å' scene=''>		<StructureSection load='5fbk' size='340' side='right'caption='[[5fbk]], [[Resolution\|resolution]] 2.10Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5fbk]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FBK OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol=5FBK FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5fbk]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FBK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5FBK FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BCT:BICARBONATE+ION'>BCT</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=TCR:CYCLOMETHYLTRYPTOPHAN'>TCR</scene>~~</td></tr>~~	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.1Å</td></tr>
-	~~<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CSO:S-HYDROXYCYSTEINE'>CSO</scene></td></tr>~~	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BCT:BICARBONATE+ION'>BCT</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=CSO:S-HYDROXYCYSTEINE'>CSO</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=TCR:CYCLOMETHYLTRYPTOPHAN'>TCR</scene></td></tr>
-	~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5fbh\|5fbh]]</td></tr>~~	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5fbk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fbk OCA], [https://pdbe.org/5fbk PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5fbk RCSB], [https://www.ebi.ac.uk/pdbsum/5fbk PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5fbk ProSAT]</span></td></tr>
-	~~<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">CASR, GPRC2A, PCAR1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])~~</td></tr>	+
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=5fbk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fbk OCA], [~~http~~://pdbe.org/5fbk PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=5fbk RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/5fbk PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=5fbk ProSAT]</span></td></tr>	+
	</table>		</table>
	== Disease ==		== Disease ==
-	[~~[http~~://www.uniprot.org/uniprot/CASR_HUMAN CASR_HUMAN]] Autosomal dominant hypocalcemia;Familial isolated hypoparathyroidism due to impaired PTH secretion;Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia type 1;Bartter syndrome with hypocalcemia. The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by mutations affecting the gene represented in this entry. Disease susceptibility is associated with variations affecting the gene represented in this entry. Homozygous defects in CASR can be a cause of primary hyperparathyroidism in adulthood. Patients suffer from osteoporosis and renal calculi, have marked hypercalcemia and increased serum PTH concentrations.	+	[https://www.uniprot.org/uniprot/CASR_HUMAN CASR_HUMAN] Autosomal dominant hypocalcemia;Familial isolated hypoparathyroidism due to impaired PTH secretion;Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia type 1;Bartter syndrome with hypocalcemia. The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by mutations affecting the gene represented in this entry. Disease susceptibility is associated with variations affecting the gene represented in this entry. Homozygous defects in CASR can be a cause of primary hyperparathyroidism in adulthood. Patients suffer from osteoporosis and renal calculi, have marked hypercalcemia and increased serum PTH concentrations.
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/CASR_HUMAN CASR_HUMAN]] Senses changes in the extracellular concentration of calcium ions. The activity of this receptor is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system.	+	[https://www.uniprot.org/uniprot/CASR_HUMAN CASR_HUMAN] Senses changes in the extracellular concentration of calcium ions. The activity of this receptor is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system.
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 27:		Line 25:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Brown~~, E M~~]]	+	[[Category: Brown EM]]
-	[[Category: Hu, J]]	+	[[Category: Hu J]]
-	[[Category: Miller~~, C L~~]]	+	[[Category: Miller CL]]
-	[[Category: Moremen~~, K W~~]]	+	[[Category: Moremen KW]]
-	[[Category: Yang~~, J J~~]]	+	[[Category: Yang JJ]]
-	[[Category: Zhang, C]]	+	[[Category: Zhang C]]
-	[[Category: Zhang, T]]	+	[[Category: Zhang T]]
-	[[Category: Zou, J]]	+	[[Category: Zou J]]
-	~~[[Category: Ectodomain]]~~	+
-	~~[[Category: G-protein coupled receptor]]~~	+
-	~~[[Category: Membrane protein]]~~	+
-	~~[[Category: Signaling protein~~]]	+

OCA at 08:09, 29 April 2020

OCA — Wed, 29 Apr 2020 08:09:12 GMT

←Older revision		Revision as of 08:09, 29 April 2020
Line 1:		Line 1:

	==Crystal structure of the extracellular domain of human calcium sensing receptor==		==Crystal structure of the extracellular domain of human calcium sensing receptor==
-	<StructureSection load='5fbk' size='340' side='right' caption='[[5fbk]], [[Resolution\|resolution]] 2.10Å' scene=''>	+	<StructureSection load='5fbk' size='340' side='right'caption='[[5fbk]], [[Resolution\|resolution]] 2.10Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5fbk]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FBK OCA]. For a <b>guided tour on the structure components</b> use [http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5FBK FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5fbk]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FBK OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5FBK FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BCT:BICARBONATE+ION'>BCT</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=TCR:CYCLOMETHYLTRYPTOPHAN'>TCR</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BCT:BICARBONATE+ION'>BCT</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=TCR:CYCLOMETHYLTRYPTOPHAN'>TCR</scene></td></tr>
	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CSO:S-HYDROXYCYSTEINE'>CSO</scene></td></tr>		<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CSO:S-HYDROXYCYSTEINE'>CSO</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5fbh\|5fbh]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5fbh\|5fbh]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5fbk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fbk OCA], [http://pdbe.org/5fbk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5fbk RCSB], [http://www.ebi.ac.uk/pdbsum/5fbk PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5fbk ProSAT]</span></td></tr>	+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">CASR, GPRC2A, PCAR1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5fbk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fbk OCA], [http://pdbe.org/5fbk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5fbk RCSB], [http://www.ebi.ac.uk/pdbsum/5fbk PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5fbk ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 26:		Line 27:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
		+	[[Category: Large Structures]]
	[[Category: Brown, E M]]		[[Category: Brown, E M]]
	[[Category: Hu, J]]		[[Category: Hu, J]]

OCA at 06:36, 26 July 2016

OCA — Tue, 26 Jul 2016 06:36:00 GMT

←Older revision		Revision as of 06:36, 26 July 2016
Line 13:		Line 13:
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/CASR_HUMAN CASR_HUMAN]] Senses changes in the extracellular concentration of calcium ions. The activity of this receptor is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system.		[[http://www.uniprot.org/uniprot/CASR_HUMAN CASR_HUMAN]] Senses changes in the extracellular concentration of calcium ions. The activity of this receptor is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system.
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Ca(2+)-sensing receptors (CaSRs) modulate calcium and magnesium homeostasis and many (patho)physiological processes by responding to extracellular stimuli, including divalent cations and amino acids. We report the first crystal structure of the extracellular domain (ECD) of human CaSR bound with Mg(2+) and a tryptophan derivative ligand at 2.1 A. The structure reveals key determinants for cooperative activation by metal ions and aromatic amino acids. The unexpected tryptophan derivative was bound in the hinge region between two globular ECD subdomains, and represents a novel high-affinity co-agonist of CaSR. The dissection of structure-function relations by mutagenesis, biochemical, and functional studies provides insights into the molecular basis of human diseases arising from CaSR mutations. The data also provide a novel paradigm for understanding the mechanism of CaSR-mediated signaling that is likely shared by the other family C GPCR [G protein (heterotrimeric guanine nucleotide-binding protein)-coupled receptor] members and can facilitate the development of novel CaSR-based therapeutics.
		+
		+	Structural basis for regulation of human calcium-sensing receptor by magnesium ions and an unexpected tryptophan derivative co-agonist.,Zhang C, Zhang T, Zou J, Miller CL, Gorkhali R, Yang JY, Schilmiller A, Wang S, Huang K, Brown EM, Moremen KW, Hu J, Yang JJ Sci Adv. 2016 May 27;2(5):e1600241. doi: 10.1126/sciadv.1600241. eCollection 2016, May. PMID:27386547<ref>PMID:27386547</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 5fbk" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>

OCA at 02:25, 13 July 2016

OCA — Wed, 13 Jul 2016 02:25:51 GMT

←Older revision		Revision as of 02:25, 13 July 2016
Line 7:		Line 7:
	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CSO:S-HYDROXYCYSTEINE'>CSO</scene></td></tr>		<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CSO:S-HYDROXYCYSTEINE'>CSO</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5fbh\|5fbh]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5fbh\|5fbh]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5fbk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fbk OCA], [http://pdbe.org/5fbk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5fbk RCSB], [http://www.ebi.ac.uk/pdbsum/5fbk PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5fbk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fbk OCA], [http://pdbe.org/5fbk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5fbk RCSB], [http://www.ebi.ac.uk/pdbsum/5fbk PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5fbk ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==

OCA at 23:26, 23 June 2016

OCA — Thu, 23 Jun 2016 23:26:27 GMT

←Older revision		Revision as of 23:26, 23 June 2016
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 5fbk ~~is ON HOLD until Paper Publication~~	+	==Crystal structure of the extracellular domain of human calcium sensing receptor==
-		+	<StructureSection load='5fbk' size='340' side='right' caption='[[5fbk]], [[Resolution\|resolution]] 2.10Å' scene=''>
-	~~Authors~~: ~~Zhang, T~~., ~~Zhang~~, C., ~~Miller~~, C.L.~~, Zou, J~~., ~~Moremen, K~~.W., ~~Brown~~, E.M., ~~Yang, J~~.J., ~~Hu, J~~.	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[5fbk]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FBK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5FBK FirstGlance]. <br>
-	~~Description~~: The ~~ectodomain~~ of a ~~membrane~~ protein	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BCT:BICARBONATE+ION'>BCT</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=TCR:CYCLOMETHYLTRYPTOPHAN'>TCR</scene></td></tr>
-	[[Category: ~~Unreleased Structures~~]]	+	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CSO:S-HYDROXYCYSTEINE'>CSO</scene></td></tr>
		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5fbh\|5fbh]]</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5fbk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fbk OCA], [http://pdbe.org/5fbk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5fbk RCSB], [http://www.ebi.ac.uk/pdbsum/5fbk PDBsum]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[[http://www.uniprot.org/uniprot/CASR_HUMAN CASR_HUMAN]] Autosomal dominant hypocalcemia;Familial isolated hypoparathyroidism due to impaired PTH secretion;Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia type 1;Bartter syndrome with hypocalcemia. The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by mutations affecting the gene represented in this entry. Disease susceptibility is associated with variations affecting the gene represented in this entry. Homozygous defects in CASR can be a cause of primary hyperparathyroidism in adulthood. Patients suffer from osteoporosis and renal calculi, have marked hypercalcemia and increased serum PTH concentrations.
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/CASR_HUMAN CASR_HUMAN]] Senses changes in the extracellular concentration of calcium ions. The activity of this receptor is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system.
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Brown, E M]]
		+	[[Category: Hu, J]]
		+	[[Category: Miller, C L]]
		+	[[Category: Moremen, K W]]
		+	[[Category: Yang, J J]]
		+	[[Category: Zhang, C]]
	[[Category: Zhang, T]]		[[Category: Zhang, T]]
-	[[Category: Yang, J.J]]
-	[[Category: Brown, E.M]]
-	[[Category: Miller, C.L]]
-	[[Category: Moremen, K.W]]
-	[[Category: Hu, J]]
	[[Category: Zou, J]]		[[Category: Zou, J]]
-	[[Category: ~~Zhang, C~~]]	+	[[Category: Ectodomain]]
		+	[[Category: G-protein coupled receptor]]
		+	[[Category: Membrane protein]]
		+	[[Category: Signaling protein]]

OCA at 14:25, 20 January 2016

OCA — Wed, 20 Jan 2016 14:25:03 GMT

←Older revision		Revision as of 14:25, 20 January 2016
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 5fbk is ON HOLD	+	The entry 5fbk is ON HOLD until Paper Publication

	Authors: Zhang, T., Zhang, C., Miller, C.L., Zou, J., Moremen, K.W., Brown, E.M., Yang, J.J., Hu, J.		Authors: Zhang, T., Zhang, C., Miller, C.L., Zou, J., Moremen, K.W., Brown, E.M., Yang, J.J., Hu, J.

OCA: Protected "5fbk" [edit=sysop:move=sysop]

OCA — Wed, 23 Dec 2015 11:24:53 GMT

Protected "5fbk" [edit=sysop:move=sysop]

←Older revision

Revision as of 11:24, 23 December 2015

OCA: New page: '''Unreleased structure''' The entry 5fbk is ON HOLD Authors: Zhang, T., Zhang, C., Miller, C.L., Zou, J., Moremen, K.W., Brown, E.M., Yang, J.J., Hu, J. Description: The ectodomain of...

OCA — Wed, 23 Dec 2015 11:24:51 GMT

New page: '''Unreleased structure''' The entry 5fbk is ON HOLD Authors: Zhang, T., Zhang, C., Miller, C.L., Zou, J., Moremen, K.W., Brown, E.M., Yang, J.J., Hu, J. Description: The ectodomain of...

New page

'''Unreleased structure'''

The entry 5fbk is ON HOLD

Authors: Zhang, T., Zhang, C., Miller, C.L., Zou, J., Moremen, K.W., Brown, E.M., Yang, J.J., Hu, J.

Description: The ectodomain of a membrane protein
[[Category: Unreleased Structures]]
[[Category: Zhang, T]]
[[Category: Yang, J.J]]
[[Category: Brown, E.M]]
[[Category: Miller, C.L]]
[[Category: Moremen, K.W]]
[[Category: Hu, J]]
[[Category: Zou, J]]
[[Category: Zhang, C]]